Your search returned 191 studies. (Get alerts for new studies):
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Bismarck, North Dakota
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Bismarck, North Dakota
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Bismarck, North Dakota
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Bismarck, North Dakota
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Bismarck, North Dakota
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Bismarck, North Dakota
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Bismarck, North Dakota
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Bismarck, North Dakota
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Bismarck, North Dakota
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Bismarck, North Dakota
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Bismarck, North Dakota
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Bismarck, North Dakota
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Conditions: Cervical Cancer
Location: Bismarck, North Dakota
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Conditions: Cervical Cancer
Location: Bismarck, North Dakota
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Conditions: Cervical Cancer
Location: Bismarck, North Dakota
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Conditions: Cervical Cancer
Location: Bismarck, North Dakota
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Stage I Bladder Cancer - Stage II Bladder Cancer - Stage III Bladder Cancer - Transitional Cell Carcinoma of the Bladder
Location: Bismarck, North Dakota
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Stage I Bladder Cancer - Stage II Bladder Cancer - Stage III Bladder Cancer - Transitional Cell Carcinoma of the Bladder
Location: Bismarck, North Dakota
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Stage I Bladder Cancer - Stage II Bladder Cancer - Stage III Bladder Cancer - Transitional Cell Carcinoma of the Bladder
Location: Bismarck, North Dakota
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Stage I Bladder Cancer - Stage II Bladder Cancer - Stage III Bladder Cancer - Transitional Cell Carcinoma of the Bladder
Location: Bismarck, North Dakota
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Bismarck, North Dakota
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Bismarck, North Dakota
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Bismarck, North Dakota
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Bismarck, North Dakota
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Bismarck, North Dakota
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Bismarck, North Dakota
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Bismarck, North Dakota
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Bismarck, North Dakota
- Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Breast Cancer - Cognitive/Functional Effects - Lung Cancer - Metastatic Cancer - Prostate Cancer
Location: Bismarck, North Dakota
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
Location: Bismarck, North Dakota
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
Location: Bismarck, North Dakota
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
Location: Bismarck, North Dakota
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Bismarck, North Dakota
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Bismarck, North Dakota
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Bismarck, North Dakota
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Bismarck, North Dakota
- Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: Male Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer
Location: Bismarck, North Dakota
- Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: Male Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer
Location: Bismarck, North Dakota
- Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: Male Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer
Location: Bismarck, North Dakota
- Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: Male Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer
Location: Bismarck, North Dakota
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Bismarck, North Dakota
- Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Location: Bismarck, North Dakota
- Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Location: Bismarck, North Dakota
- Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Location: Bismarck, North Dakota
- Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Location: Bismarck, North Dakota
- Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Location: Bismarck, North Dakota
- Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Location: Bismarck, North Dakota
- Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Conditions: Brain and Central Nervous System Tumors
Location: Bismarck, North Dakota
- Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Conditions: Brain and Central Nervous System Tumors
Location: Bismarck, North Dakota
- Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Conditions: Brain and Central Nervous System Tumors
Location: Bismarck, North Dakota
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
Location: Bismarck, North Dakota
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
Location: Bismarck, North Dakota
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
Location: Bismarck, North Dakota
- Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Conditions: Preterm Birth
Location: Bismarck, North Dakota
- Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors
Location: Bismarck, North Dakota
- Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Bismarck, North Dakota
- Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Bismarck, North Dakota
- Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Bismarck, North Dakota
- Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Bismarck, North Dakota
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: Bismarck, North Dakota
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: Bismarck, North Dakota
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
Location: Bismarck, North Dakota
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
Location: Bismarck, North Dakota
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
Location: Bismarck, North Dakota
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
Location: Bismarck, North Dakota
- Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
Conditions: Malignant Mesothelioma
Location: Bismarck, North Dakota
- Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
Conditions: Malignant Mesothelioma
Location: Bismarck, North Dakota
- Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
Conditions: Malignant Mesothelioma
Location: Bismarck, North Dakota
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Bismarck, North Dakota
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Bismarck, North Dakota
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Bismarck, North Dakota
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Bismarck, North Dakota
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Bismarck, North Dakota
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Bismarck, North Dakota
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Bismarck, North Dakota
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Bismarck, North Dakota
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Bismarck, North Dakota
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Bismarck, North Dakota
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Conditions: Diarrhea - Gastrointestinal Complications - Unspecified Adult Solid Tumor, Protocol Specific
Location: Bismarck, North Dakota
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Conditions: Diarrhea - Gastrointestinal Complications - Unspecified Adult Solid Tumor, Protocol Specific
Location: Bismarck, North Dakota
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Conditions: Diarrhea - Gastrointestinal Complications - Unspecified Adult Solid Tumor, Protocol Specific
Location: Bismarck, North Dakota
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
Conditions: Colon Cancer and Rectal Cancer
Location: Bismark, North Dakota
- Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
Conditions: Metastatic Pancreatic Adenocarcinoma
Location: Bismarck, North Dakota
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavit
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Bismarck, North Dakota
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavit
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Bismarck, North Dakota
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavit
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Bismarck, North Dakota
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavit
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Bismarck, North Dakota
- Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
Conditions: Cognitive/Functional Effects - Metastatic Cancer - Neurotoxicity - Radiation Toxicity - Unspecified Adult Solid Tumor, Protocol Specific
Location: Bismarck, North Dakota
- Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
Conditions: Cognitive/Functional Effects - Metastatic Cancer - Neurotoxicity - Radiation Toxicity - Unspecified Adult Solid Tumor, Protocol Specific
Location: Bismarck, North Dakota
- Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
Conditions: Breast Cancer - Cancer Survivor - Hot Flashes
Location: Bismarck, North Dakota
- Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
Conditions: Breast Cancer - Cancer Survivor - Hot Flashes
Location: Bismarck, North Dakota
- Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
Conditions: Breast Cancer - Cancer Survivor - Hot Flashes
Location: Bismarck, North Dakota
- Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma
Conditions: Smoldering Multiple Myeloma
Location: Bismarck, North Dakota
- AMG 151 Amgen Protocol Number 20100761
Conditions: Diabetes Mellitus
Location: Bismarck, North Dakota
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Bismarck, North Dakota
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Bismarck, North Dakota
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Bismarck, North Dakota
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Bismarck, North Dakota
- Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
Conditions: Chemotherapy-induced Neutropenia - Breast Cancer
Location: Bismarck, North Dakota
- Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcom
Conditions: Sarcoma
Location: Bismarck, North Dakota
- Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcom
Conditions: Sarcoma
Location: Bismarck, North Dakota
- Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcom
Conditions: Sarcoma
Location: Bismarck, North Dakota
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Bismarck, North Dakota
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Bismarck, North Dakota
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Bismarck, North Dakota
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Bismarck, North Dakota
- A Study Using MABp1 To Increase Overall Survival In Patients With Colorectal Cancer And Weight Loss
Conditions: Metastatic Colorectal Cancer - Cachexia - Weight Loss
Location: Bismarck, North Dakota
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
Conditions: Neoplasms, Breast - Breast Cancer
Location: Bismarck, North Dakota
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: Bismarck, North Dakota
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: Bismarck, North Dakota
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: Bismarck, North Dakota
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: Bismarck, North Dakota
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: Bismarck, North Dakota
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Bismarck, North Dakota
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Bismarck, North Dakota
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Bismarck, North Dakota
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Bismarck, North Dakota
- Juvenile Idiopathic Arthritis (JIA) Registry
Conditions: Juvenile Idiopathic Arthritis
Location: Bismarck, North Dakota
- Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Conditions: Myelodysplastic Syndromes
Location: Bismark, North Dakota
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Bismarck, North Dakota
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Bismarck, North Dakota
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Bismarck, North Dakota
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Bismarck, North Dakota
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
Location: Bismarck, North Dakota
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
Location: Bismarck, North Dakota
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
Location: Bismarck, North Dakota
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
Location: Bismarck, North Dakota
- Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Conditions: Light Chain Deposition Disease - Smoldering Multiple Myeloma
Location: Bismarck, North Dakota
- Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Conditions: Light Chain Deposition Disease - Smoldering Multiple Myeloma
Location: Bismarck, North Dakota
- Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Conditions: Light Chain Deposition Disease - Smoldering Multiple Myeloma
Location: Bismarck, North Dakota
- Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Conditions: Light Chain Deposition Disease - Smoldering Multiple Myeloma
Location: Bismarck, North Dakota
- Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy
Conditions: Lymphoma, Follicular
Location: Bismarck, North Dakota
- A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza.
Conditions: Influenza, Human
Location: Bismarck, North Dakota
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-re
Conditions: Herpes Zoster
Location: Bismarck, North Dakota
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-re
Conditions: Herpes Zoster
Location: Bismarck, North Dakota
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-re
Conditions: Herpes Zoster
Location: Bismarck, North Dakota
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: Bismarck, North Dakota
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: Bismarck, North Dakota
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: Bismarck, North Dakota
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: Bismarck, North Dakota
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Bismarck, North Dakota
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Bismarck, North Dakota
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Bismarck, North Dakota
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Bismarck, North Dakota
- TRINOVA-2: Trebananib in Ovarian Cancer-2
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cancer
Location: Bismarck, North Dakota
- A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Re
Conditions: Prostate Cancer Metastatic
Location: Bismarck, North Dakota
- Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Conditions: Cancer - Hematologic Malignancies - Multiple Myeloma - Oncology - Bone Metastases - Multiple Myeloma Bone Lesions
Location: Bismarck, North Dakota
- S0820, Adenoma and Second Primary Prevention Trial
Conditions: Colorectal Neoplasms
Location: Bismarck, North Dakota
- Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Conditions: Pain - Advanced Cancer
Location: Bismarck, North Dakota
- Efficacy and Safety Study of NeuVax(TM)(Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Conditions: HER2 Negative Breast Cancer
Location: Bismarck, North Dakota
- Study Of Dacomitinib In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO
Conditions: Non Small Cell Lung Cancer (NSCLC)
Location: Bismarck, North Dakota
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Bismarck, North Dakota
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Bismarck, North Dakota
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Bismarck, North Dakota
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Bismarck, North Dakota
- Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abir
Conditions: Prostate Cancer - Castration Resistant Prostate Cancer - Pain - Prostatic Neoplasms
Location: Bismark, North Dakota
- Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metasta
Conditions: Breast Cancer
Location: Bismark, North Dakota
- Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Conditions: Postmenopausal Women With Osteoporosis
Location: Bismarck, North Dakota
- Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse I
Conditions: Fibrosing Colonopathy in Patients With Cystic Fibrosis
Location: Bismark, North Dakota
- Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
Location: Bismarck, North Dakota
- Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
Location: Bismarck, North Dakota
- Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
Location: Bismarck, North Dakota
- Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
Location: Bismarck, North Dakota
- S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Bismarck, North Dakota
|